Clinical implementation of an uveitis prediction model

Clinical implementation of an uveitis prediction model - Uveitis prediction model

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON46803

Enrollment

250

Registered

2018-05-16

Start date

2019-04-04

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uveitis

Interventions

Introduction of information of a predictive model.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Non-infectious uveitis. - Age >= 18 years. - Informed consent.

Exclusion criteria

Exclusion criteria: - Major eye condition preventing any VA improvement or reduction (such as end stage glaucoma, end stage corneal diseases, end stage macular degeneration). - Suspected or proven infectious uveitis. - Masquerade syndromes (such as intraocular B cell lymphoma). - Patients for whom all data of the first year since onset of their uveitis are missing. - Patients for whom, since onset of their uveitis, data (> 3 years) are missing.

Design outcomes

Primary

Measure	Time frame
Best corrected visual acuity.	—

Secondary

Measure	Time frame
Duration and dose immunosuppressives. See Ch. 8 of the protocol.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)